https://germanhealthreview.com/article/914348065-prolific-studio-expands-3d-medical-and-character-animation-services-for-healthcare-and-enterprise-brands German Health Review en PressRelease 2026-05-22T13:28:13+00:00 Prolific Studio Expands 3D Medical and Character Animation Services for Healthcare and Enterprise Brands https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864643-123-2240x1260.png https://germanhealthreview.com/article/914338299-haartransplantation-t-rkei-vs-deutschland-vs-ungarn-was-kostet-eine-behandlung-wirklich German Health Review en PressRelease 2026-05-22T13:14:33+00:00 Haartransplantation Türkei vs. Deutschland vs. Ungarn: Was kostet eine Behandlung wirklich? https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864582-germanpress-1200x628.jpeg https://germanhealthreview.com/article/912981649-protecting-every-scenario-rhino-rescue-unveils-annual-matrix-of-emergency-medical-innovations German Health Review en PressRelease 2026-05-22T08:00:00+00:00 Protecting Every Scenario: Rhino Rescue Unveils Annual Matrix of Emergency Medical Innovations https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864165--2000x2000.jpeg https://germanhealthreview.com/article/914341229-chmp-issues-positive-opinion-for-jascayd-nerandomilast-bringing-a-new-ipf-and-ppf-therapy-closer-to-patients-in-the-eu German Health Review en PressRelease 2026-05-22T12:15:00+00:00 CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://germanhealthreview.com/article/914131234-kfsh-calls-for-scaling-ai-from-pilots-to-patient-impact-at-world-economic-forum-health-roundtable German Health Review en PressRelease 2026-05-21T21:12:57+00:00 KFSH Calls for Scaling AI from Pilots to Patient Impact at World Economic Forum Health Roundtable https://germanhealthreview.com/article/914280549-china-approves-hernexeos-as-first-targeted-oral-treatment-option-for-her2-mutant-advanced-nsclc-at-initial-diagnosis German Health Review en PressRelease 2026-05-22T07:45:00+00:00 China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://germanhealthreview.com/article/914159763-boehringer-ingelheim-s-oncology-portfolio-shows-strong-promise-across-multiple-cancers-at-asco-2026 German Health Review en PressRelease 2026-05-21T21:00:00+00:00 Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026 https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://germanhealthreview.com/article/914005716-kfsh-spotlights-ai-s-role-in-expanding-patient-access-while-preserving-human-centered-care German Health Review en PressRelease 2026-05-21T08:39:50+00:00 KFSH Spotlights AI’s Role in Expanding Patient Access While Preserving Human-Centered Care